Wolverine Trading
XFOR icon

Wolverine Trading’s X4 Pharmaceuticals XFOR Stock Holding History

Wolverine Trading’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,322
Closed -$32.1K – 6012
2024
Q4 		$32.1K Buy
+1,322
New +$21.1K ﹤0.01% 5060
2023
Q4 		– Sell
-492
Closed -$12K – 5344
2023
Q3 		$16.1K Buy
+492
New +$21.5K ﹤0.01% 4344

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's XFOR Position: Q1 2025 in Review

Wolverine Trading sold out of X4 Pharmaceuticals (XFOR) in Q1 2025, closing a stake of 1,322 shares — an estimated $32.1K sold.

Wolverine Trading first reported a position in XFOR in Q3 2023 and held it in 2 quarters. The position peaked at $32.1K in Q4 2024. 93 funds tracked by Wall St. Rank hold XFOR as of Q1 2025.

  • Wolverine Trading reported no remaining X4 Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 1,322 X4 Pharmaceuticals shares in Q1 2025, an estimated $32.1K.
  • Wolverine Trading first reported a position in X4 Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • Wolverine Trading's X4 Pharmaceuticals position peaked at $32.1K in Q4 2024.
  • 93 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.